Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2011-04-12
2011-04-12
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S473000, C514S613000, C514S645000, C424S422000, C424S423000, C424S427000, C424S443000
Reexamination Certificate
active
07923439
ABSTRACT:
The present disclosure provides compositions including a first component including at least one phospholipid possessing at least one vinyl group, a second component including a furanone possessing vinyl and/or acrylate groups, and a third component including a hydroxamate. Compositions, medical devices, and coatings including copolymers and blends of the foregoing components are also provided.
REFERENCES:
patent: 3187752 (1965-06-01), Glick
patent: 3565077 (1971-02-01), Glick
patent: 4014973 (1977-03-01), Thompson
patent: 4027676 (1977-06-01), Mattei
patent: 4043344 (1977-08-01), Landi et al.
patent: 4047533 (1977-09-01), Perciaccante et al.
patent: 4190720 (1980-02-01), Shalaby
patent: 4201216 (1980-05-01), Mattei
patent: 4582052 (1986-04-01), Dunn et al.
patent: 4605730 (1986-08-01), Shalaby et al.
patent: 4624256 (1986-11-01), Messier et al.
patent: 4700704 (1987-10-01), Jamiolkowski et al.
patent: 4705820 (1987-11-01), Wang et al.
patent: 4711241 (1987-12-01), Lehmann
patent: 4788979 (1988-12-01), Jerrett et al.
patent: 4791929 (1988-12-01), Jerrett et al.
patent: 4994074 (1991-02-01), Bezwada et al.
patent: 5019093 (1991-05-01), Kaplan et al.
patent: 5032638 (1991-07-01), Wang et al.
patent: 5047048 (1991-09-01), Bezwada et al.
patent: 5059213 (1991-10-01), Chesterfield et al.
patent: 5100433 (1992-03-01), Bezwada et al.
patent: 5133738 (1992-07-01), Korthoff et al.
patent: 5133739 (1992-07-01), Bezwada et al.
patent: 5181923 (1993-01-01), Chesterfield et al.
patent: 5226912 (1993-07-01), Kaplan et al.
patent: 5261886 (1993-11-01), Chesterfield et al.
patent: 5306289 (1994-04-01), Kaplan et al.
patent: 5318575 (1994-06-01), Chesterfield et al.
patent: 5352515 (1994-10-01), Jarrett et al.
patent: 5370031 (1994-12-01), Koyfman et al.
patent: 5383387 (1995-01-01), Chesterfield et al.
patent: 5662682 (1997-09-01), Chesterfield et al.
patent: 5667528 (1997-09-01), Colligan
patent: 5716376 (1998-02-01), Roby et al.
patent: 6177094 (2001-01-01), Jiang
patent: 6203564 (2001-03-01), Hutton et al.
patent: 2004/0213758 (2004-10-01), Sefton et al.
patent: 2007/0104678 (2007-05-01), May et al.
patent: 2007/0160655 (2007-07-01), Sefton et al.
patent: 1669093 (2006-06-01), None
patent: 2028208 (2009-02-01), None
patent: 2630728 (1989-11-01), None
patent: WO01/30795 (2001-05-01), None
patent: WO2006/002050 (2006-01-01), None
patent: WO2006/002506 (2006-01-01), None
patent: WO2006/133569 (2006-12-01), None
patent: WO2008/143654 (2008-11-01), None
patent: WO2008/144247 (2008-11-01), None
patent: WO2008/144248 (2008-11-01), None
European Search Report for EP 09252411.5-1214 date of completion is Jan. 22, 2010 (4 pages).
Hadba Ahmad
Stopek Joshua
Henley, III Raymond J
Tyco Healthcare Group LP
LandOfFree
Hydroxamate compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamate compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamate compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2738182